<DOC>
	<DOC>NCT02690324</DOC>
	<brief_summary>development of skin adhesive patches for the monitoring and prediction of mental disorders</brief_summary>
	<brief_title>The Development of Skin Adhesive Patches for the Monitoring and Prediction of Mental Disorders</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>the existence of a current Major depressive disorder or panic disorder during the screening and baseline visits, per the MiniInternational Neuropsychiatric Interview (Sheehan et al., 1998) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM5) scored at least 16 on the HDRS17 (Hamilton, 1960) for MDD and 7 on the Panic disorder severity scale for panic disorder patients at the baseline visits. Patients who had psychotic disorder (e.g., schizophrenia or delusional disorder), bipolar affective disorder,active alcohol or drug use disorder, neurological illness including significant cognitive impairment or Parkinson's disease, mental retardation, significant medical conditions, epilepsy, histories of alcohol or drug dependence, personality disorders, or brain damages patients who were at serious risk for suicide of homicide</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>